Cerebral infarction due to thrombosis of other precerebral artery
Methodology & AI Transparency ⓘ
Cerebral infarction due to thrombosis of other precerebral artery Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Recognized across U.S.
- 2 Real-world patient consensus: Clinical coding for Cerebral infarction due to thrombosis of other precerebral artery uses ICD-10 I63.09 across Brain & Neurology specialty care.
- 3 Typical cash cost range: Workup highlights for Cerebral infarction due to thrombosis of other precerebral artery (I63.09): neurorehabilitation tracking [Cerebral infarction due to thrombosis of other precerebral artery I63.09].
- 4 Top reported side effects / signs: Objective lab/clinical target for Cerebral infarction due to thrombosis of other precerebral artery: HbA1c & Blood in Cerebral infarction due to thrombosis of other precerebral artery (I63.09: Pressure Neuro-Targets) (BP < 120/75 mmHg; HbA1c < 5.7% (I63.09)) and Serum Vitamin B12 in Cerebral infarction due to thrombosis of other precerebral artery (I63.09: & Methylmalonic Acid).
Ask our AI Specialists anything about Cerebral infarction due to thrombosis of other precerebral artery
What Is Cerebral infarction due to thrombosis of other precerebral artery?
Recognized across U.S. clinical coding as I63.09 (Brain & Neurology), Cerebral infarction due to thrombosis of other precerebral artery is evaluated via neurorehabilitation tracking [Cerebral infarction due to thrombosis of other precerebral artery I63.09] to align day-to-day symptom relief with long-term physiological stability.
Pathophysiology, Underlying Causes & Clinical Presentation
At the cellular and tissue level in brain & neurology, Cerebral infarction due to thrombosis of other precerebral artery (I63.09) involves axonal transport impairment [Cerebral infarction due to thrombosis of other precerebral artery I63.09]. progression correlates with shifts in HbA1c & Blood in Cerebral infarction due to thrombosis of other precerebral artery (I63.09: Pressure Neuro-Targets) (BP < 120/75 mmHg; HbA1c < 5.7% (I63.09)).
Common Symptoms & Clinical Signs
- • Presentation of Cerebral infarction due to thrombosis of other precerebral artery (I63.09): muscle stiffness, spasticity, in Cerebral infarction due to thrombosis of other precerebral artery (I63.09: or fatigable neuromuscular)
- • Secondary Cerebral infarction due to thrombosis of other precerebral artery clinical sign: focal motor weakness, in Cerebral infarction due to thrombosis of other precerebral artery (I63.09: resting or action)
- • Symptom flares in Cerebral infarction due to thrombosis of other precerebral artery correlating with HbA1c & Blood in Cerebral infarction due to thrombosis of other precerebral artery (I63.09: Pressure Neuro-Targets) deviation outside BP < 120/75 mmHg; HbA1c < 5.7% (I63.09)
- • Functional brain & neurology impact requiring neurorehabilitation tracking [Cerebral infarction due to thrombosis of other precerebral artery I63.09] evaluation (I63.09)
Cerebral infarction due to thrombosis of other precerebral artery Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | I63.09 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Neurology, Stroke & Movement Disorders | NLM Clinical Tables |
| Diagnostic / Lab Marker: HbA1c & Blood in Cerebral infarction due to thrombosis of other precerebral artery (I63.09: Pressure Neuro-Targets) | BP < 120/75 mmHg; HbA1c < 5.7% (I63.09) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Serum Vitamin B12 in Cerebral infarction due to thrombosis of other precerebral artery (I63.09: & Methylmalonic Acid) | B12 > 500 pg/mL; MMA < 240 nmol/L (I63.09) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Carotid Duplex / in Cerebral infarction due to thrombosis of other precerebral artery (I63.09: Cerebral Perfusion) | No hemodynamically significant stenosis (I63.09) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Cerebral infarction due to thrombosis of other precerebral artery
Treatment selection for Cerebral infarction due to thrombosis of other precerebral artery depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Cerebral infarction due to thrombosis of other precerebral artery)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Three Low-Dose blood-pressure-lowering Agents in a Single Pill after: What a 1,670-Participant Study Found Among patients with intracerebral hemorrhage, treatment with a combination of three low-dose blood-pressure-lowering agents in a single pill, in addition to standard care, was associated with a lower incidence of recurrent... The New England journal of medicine • 2026-04-23 • Phase III Randomized Trial | N = 1,670 | 96/100 | PMID 42019018 ↗ |
| New Insights on Association of obstructive sleep apnea and cerebral small vessel: What a 6,036-Participant Study Found Current evidence suggests that moderate to severe sleep apnea is positively related to WMH and SBI, but not CMBs or PVS, which suggests that OSA may contribute to the pathogenesis of CSVD. Sleep • 2020-04-15 • Meta-Analysis | N = 6,036 | 94/100 | PMID 31696917 ↗ |
| New Insights on Optimization of cerebral oxygenation based on regional cerebral oxygen saturation: What a 879-Participant Study Found Among patients undergoing carotid endarterectomy, optimization of cerebral oxygenation based on rSO 2 did not reduce the occurrence of cerebral ischemic lesions postoperatively compared with controlled hypertensive therapy. Anaesthesia, critical care & pain medicine • 2024-08-15 • Phase III Randomized Trial | N = 879 | 93/100 | PMID 38710323 ↗ |
| New Insights on IncobotulinumtoxinA Efficacy/Safety in Upper-Limb Spasticity in children Cerebral: What a 350-Participant Study Found Data provide evidence for sustained real-world benefits and safety of multipattern incobotulinumtoxinA treatment in children and adolescents with upper-limb spasticity. Pediatric neurology • 2021-10-15 • Phase III Randomized Trial | N = 350 | 93/100 | PMID 34339951 ↗ |
| New Insights on Effect of Moderate and Severe Persistent high blood sugar on Outcomes in Patients: What a 1,000-Participant Study Found Persistent high blood sugar, either moderate or severe, increased the risk of death or disability in nondiabetic patients with intracerebral hemorrhage. Stroke • 2022-04-15 • Phase III Randomized Trial | N = 1,000 | 90/100 | PMID 34844422 ↗ |
Cerebral infarction due to thrombosis of other precerebral artery Patient Community & “People Like Me” Threads
Filter Cerebral infarction due to thrombosis of other precerebral artery community threads and patient logs by age, biological sex, dosage, and treatment duration.